Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14386 participants
INTERVENTIONAL
2023-05-10
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Mailers Promoting Mammogram Screening
NCT04555902
Messaging Strategies to Reduce Breast Cancer Over-screening in Older Women
NCT05821023
Evaluating Mammography Communication Approaches
NCT07228234
Communicating Objective Risk for Personalized Decision Making About Mammography
NCT01686360
Overdiagnosis and Breast Cancer Screening Decisions
NCT07071415
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard postcard
Patients in this arm will receive a postcard with words and an image, typical of outreach in prior years, encouraging them to schedule their annual mammograms.
Postcard
Postcard with phone number to call for help scheduling a mammogram.
Formal letter
Patients in this arm will receive a letter from the Geisinger Health Plan (on Geisinger letterhead) noting that they're overdue for a mammogram and encouraging them to schedule.
Letter
Letter with phone number to call for help scheduling a mammogram.
Auto-dialer
Patients in this arm will receive a call from an auto-dialer with a message noting that they're overdue for a mammogram and encouraging them to schedule.
Auto-dialer
Auto-dialer with option to press button for help scheduling a mammogram.
Live call
Patients in this arm will receive a call from a Geisinger Health Plan representative noting that they're overdue for a mammogram and encouraging them to schedule (and helping them schedule if they are interested).
Live call
Live call offering help scheduling a mammogram.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Postcard
Postcard with phone number to call for help scheduling a mammogram.
Letter
Letter with phone number to call for help scheduling a mammogram.
Auto-dialer
Auto-dialer with option to press button for help scheduling a mammogram.
Live call
Live call offering help scheduling a mammogram.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Overdue for annual mammogram
* Continuously enrolled with the Geisinger Health Plan as of October 1, 2021
* Can be contacted via both phone and mail
Exclusion Criteria
* Had a mammogram as of October 1, 2021
* In hospice, using hospice services, or receiving palliative care as of January 1, 2023
* Medicare members 66 years of age or above at time of outreach, who are institutionalized or have both frailty and advanced illness
* Had a bilateral mastectomy at any time
51 Years
74 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Geisinger Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amir Goren
Program Director, Behavioral Insights Team
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amir Goren, PhD
Role: PRINCIPAL_INVESTIGATOR
Geisinger Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Geisinger
Danville, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-0369
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.